Last reviewed · How we verify
NCT03749239
Effects of Collagen Protein on the Amino Acid Profile of the Blood
NA trial testing Collagen protein in Collagen Protein in 10 participants. Completed in 1 March 2019.
15 December 2018
Quick facts
| Lead sponsor | University of Aarhus |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 10 |
| Start date | 8 November 2018 |
| Primary completion | 15 December 2018 |
| Estimated completion | 1 March 2019 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Collagen protein
Conditions studied
- Collagen Protein — all drugs for Collagen Protein →
Sponsor
University of Aarhus
Who can join
Adults 18 to 30, male only, with Collagen Protein. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project aims to investigate the absorption of enzymatically hydrolysed and non-enzymatically hydrolysed collagen on the Amino acid profile of the blood
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Enzymatic Hydrolysis of a Collagen Hydrolysate Enhances Postprandial Absorption Rate-A Randomized Controlled Trial.
Skov K, Oxfeldt M, Thøgersen R, Hansen M, et al · · 2019 · cited 44× · PMID 31086034 · DOI 10.3390/nu11051064
Verify or expand the search:
- PubMed search for NCT03749239
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Collagen protein
Trials testing the same drug.
- NCT06435637 — Effects of Ingesting Multiple Boluses of Collagen on Muscle & Skin Connective Protein Synthesis in Vivo in Humans · NA · not yet recruiting
Other recruiting trials for Collagen Protein
Currently open trials in the same condition.
- NCT06725082 — Impact of Recombinant Humanized Type III Collagen on the Immediate and Long-term Effects of Breast Tumor Surgery · Phase 1 · recruiting
Other University of Aarhus trials
Trials by the same sponsor.
- NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
- NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
- NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
- NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03749239 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
- Last refreshed: 9 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03749239.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing